BGPT: Paper Review: Eco1 Is a Novel Acetyltransferase that Can Acetylate Proteins Involved in Cohesion

Fuel Your Discoveries

Quick Answer Copied

Core claim (skeptically)

Eco1 is proposed to be a GNAT-family acetyltransferase that acetylates cohesin components (notably Scc1 and Scc3) during sister chromatid cohesion establishment in S. cerevisiae, with in vitro activity supported by 14C-acetyl-CoA labeling, acetylation-site mapping for Scc1, and loss-of-function via Eco1 catalytic-site mutations—all while histone acetylation was not detected under the tested conditions.

Long Answer

Eco1 Paper Review (Critical, Evidence-Based, Inline-Cited)

Paper: 10.1016/S0960-9822(02)00681-4 (Current Biology, received Nov 20 2001; accepted Dec 19 2001; published Feb 19 2002 as extracted from the provided full-text header)

What BGPT extracts from the provided full-text

Sequence analysis is used to place Eco1 in the GNAT acetyltransferase superfamily, including mention of a GNAT acetyltransferase local hit (PF00583) and conserved motifs within an ACT-like region.
Biochemical assays: purified recombinant GST-Eco1 incubated with 14C-acetyl-CoA shows detectable acetyl labeling; mutants in conserved GNAT-like residues reduce activity; Eco1 self-acetylation is detected; Eco1 acetylates cohesin components in vitro.
Substrate evidence: Eco1 acetylates cohesin complex proteins (Scc1 and Scc3), with acetylation-site mapping on Scc1 including Lys210; Eco1 does not acetylate tested histone substrates under the reported in vitro conditions.
Functional inference: the authors connect Eco1 enzymatic activity to establishment of sister chromatid cohesion during S phase via temperature-sensitive alleles and cohesion phenotypes (as discussed throughout the provided text).

VISUAL 1 — Substrate specificity as reported (in vitro)

Interpretation (skeptical)

The plot uses a strict interpretation of what is explicitly stated in the provided full-text: cohesin components (Scc1 and Scc3) are acetylated; Pds5 is mentioned as tested in the acetylation context; histone acetylation is described as not observed in their assays.

VISUAL 2 — Scc1 lysine acetylation sites (as listed in the provided text)

Interpretation (what’s solid vs uncertain)

Solid: the provided full-text lists multiple Scc1 lysines as acetylated and highlights that Lys210 is among them, with K210R described as abolishing detectable acetylation.
Uncertain: the exact efficiency or stoichiometry of each lysine acetylation event is not provided in the extracted text; therefore, we should not infer which lysines dominate functional output from residue lists alone.

VISUAL 3 — Eco1 GNAT catalytic logic from mutations (qualitative)

The provided full-text explicitly discusses Eco1 catalytic-site changes (e.g., G211D and glycine-to-aspartate substitutions in motif A/ACT region) that reduce/abolish enzymatic activity and connect with temperature-sensitive phenotypes in vivo.
Critical note: the plot is intentionally coarse because the extracted text does not provide numeric activity rates; for rigorous comparison, the original gels/blots would need densitometry values.

Mechanistic story (VISUAL → EXPLAIN)

Hypothesized pathway (as the paper presents it)

Step 1 (identity): Eco1 is a GNAT-like acetyltransferase with a GNAT core (ACT) and an N-terminal C2H2 zinc-finger-like region.
Step 2 (catalysis): Eco1 requires an intact fold/catalytic residues to transfer acetyl groups from acetyl-CoA; it autoacetylates in vitro.
Step 3 (substrates): Eco1 acetylates cohesin proteins in vitro (Scc1 and Scc3; Scc1 acetylation sites mapped including Lys210).
Step 4 (biology): Eco1’s requirement for establishing cohesion during S phase is used to argue that Eco1-mediated acetylation regulates cohesion establishment (directly or indirectly).

Critical evaluation (known vs inferred vs uncertain)

What the evidence most directly supports

Eco1 is an acetyltransferase capable of transferring acetyl groups (supports: self-acetylation, dependence on structural/catalytic residue integrity).
Eco1 acetylates cohesin components in vitro and the Scc1 lysine acetylation map includes multiple lysines, including Lys210 (with a K210R test described).
Histone acetylation was not detected under the tested conditions (but this supports “not detected” rather than “cannot happen”).

Key uncertainties / blind spots highlighted by the text itself

In vivo target specificity beyond tested substrates is not fully established: the paper notes inability to detect acetylation of additional cohesin-related substrates (e.g., Pds5 mention and broader inability to detect other substrates in vivo as described in the provided text).
Antibody detection limitations: reliance on anti-acetyl-lysine detection in Western blotting means isoform/epitope/context could affect detectability (a measurement bias intrinsic to the method).
In vitro ≠ in vivo: biochemical assays show catalytic capability on recombinant substrates, but cellular regulation (cofactors, compartmentalization, timing, substrate accessibility) is not proven from in vitro activity alone.

What would most change the paper’s conclusions?

If Eco1 catalytic-site mutants did not reduce cohesin acetylation at the relevant lysines in vivo (or if cohesion phenotypes occurred without changes in cohesin acetylation), the mechanistic linkage would weaken.
If histone acetylation were detectable under additional conditions/targets not tested here, the claimed specificity “not histones” would be condition-dependent rather than absolute.

Methods & experimental design critique (rigor)

Strength: combinational logic of (i) sequence-domain inference, (ii) recombinant enzymatic activity assays, (iii) catalytic-site mutagenesis effects, and (iv) substrate acetylation mapping for Scc1 provides a coherent internal pipeline.
Potential weakness: the specificity claim relies on “not detected” outcomes for some substrates; negative results can be due to detection sensitivity, non-physiological substrate presentation, or timing/context mismatch.
Interpretation risk: biochemical activity on recombinant cohesin does not automatically prove that the observed lysine acetylation causes the cohesion phenotype; it establishes plausibility and offers testable causal residues.

BGPT “next steps” (what to do with this paper)

Build a lysine-focused test plan around Scc1 Lys210 (and the other mapped lysines) to determine whether each site is necessary/sufficient for cohesion phenotypes, rather than only for acetylation detection.
Quantify acetylation dynamics during S phase directly in vivo (lysine-resolved), to distinguish “Eco1 acetylates cohesin” from “Eco1 acetylation is the causal cohesion control event.”
Compare detected cohesin acetylation profiles across ecotypes/species/isoforms only if new data support equivalence; otherwise treat the cohesin-acetylation relationship as potentially species/assay dependent.

Author reviews (bespoke BGPT deep dives)

Feedback:

Updated: April 08, 2026